🌐 EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

← Trials
🧪

Wavefront-guided LASIK Surgery Compared to Ray Tracing-Guided LASIK Surgery

RecruitingNAAges 22 Years - 59 YearsAllStanford University
NCT07078799 on ClinicalTrials.gov ↗
💬

In plain words

What the trial is, and whether it could suit you

We are enrolling participants aged 22 and older to have LASIK surgery in both eyes. We will perform wavefront-guided LASIK in one eye and ray tracing-guided LASIK in the fellow eye of each participant. We are trying to see if there are any differences in the efficacy between the two types of LASIK procedures.

Sign in to get the eligibility rules as simple questions to take to your doctor.

Sign in
📋 Eligibility rules (as published)
Inclusion Criteria: 1. Age 22 and older 2. People with healthy eyes: 1. No abnormal corneal shape 2. No excessively thin corneas 3. No eye diseases such as glaucoma or cataracts 3. Nearsightedness between -1.00 diopters and -10.00 diopters. 4. Subjects with less than or equal to 3.00 diopters of astigmatism. 5. Subjects must have similar levels of nearsightedness in each eye. Exclusion Criteria: 1. Subjects under the age of 22. 2. Subjects with excessively thin corneas. 3. Subjects with topographic evidence of keratoconus. 4. Subjects with ectactic eye disorders. 5. Subjects with autoimmune diseases. 6. Subjects who are pregnant or nursing at the time of surgery. (The FDA-approved labelling indications for LASIK specifically excludes patients who are pregnant or nursing. There is no strict prohibition not to become pregnant during the one year study period) 7. They can not be more than 1.5 diopter of difference between eyes. 8. Subjects with more than 3.00 diopters of astigmatism 9. Subjects with disimilar levels of astigmatism in each eye (They can not have more than 0.75 diopters of difference between eyes) -
💊

What it tests

  • LASIK
  • LASIK
📍

Where

1 site
Byers Eye Institute at Stanford University School of Medicine
Palo Alto, United States
🤝 Taking part is your choice, and you can leave at any time. Only the trial team can confirm you are eligible — always decide together with your own doctor.
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy